| 发明名称 |
Sublingual Administration of Statins |
| 摘要 |
The invention provides a pharmaceutical composition for the transmucosal delivery of a statin, said composition comprising a statin and a carrier in which said statin is soluble or forms a suspension or emulsion. The invention also provides a pharmaceutical composition comprising a statin for use in inhibiting cholesterol synthesis in vivo, where in said use said composition is delivered by the transmucosal route. |
| 申请公布号 |
US2015328142(A1) |
申请公布日期 |
2015.11.19 |
| 申请号 |
US201214365798 |
申请日期 |
2012.12.14 |
| 申请人 |
LondonPharma Ltd. |
发明人 |
Sams Martin James;High Juliet Victoria;Jamieson Paul Andrew;Booles Clive |
| 分类号 |
A61K9/00;A61K47/10;A61K31/405;A61K47/14;A61K31/366;A61K31/22 |
主分类号 |
A61K9/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A pharmaceutical composition for use in a method of preventing or treating hypercholesterolaemia, dyslipidaemia, cardiovascular disease or cancer; or an effect of any of these conditions, in an individual, wherein the composition is delivered by sublingual administration as a spray, and wherein said composition comprises:
a statin; and a carrier in which said statin is soluble or forms a suspension or emulsion. |
| 地址 |
Norwich, Norfolk GB |
